High purity 99% factory price Professional Supply API Dapagliflozin Powder powder

High purity 99% factory price Professional Supply API Dapagliflozin Powder powder

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 25.0000 -150.0000

1 Kilogram

FOB Price:USD 25.0000 -150.0000

Min.Order :1 Kilogram
Purity: 99% up
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Dapagliflozin Powder factory price High purity 99%

Quick Details

Appearance:White powder
Application: Pharmaceutical Intermediate
PackAge:1kg/bag ;5kg/drum:25KG/drum
ProductionCapacity:20|Metric Ton|Month
Storage:in low tempreture
Transportation:in low tempreture

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier .

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

Why choose us

1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin

Details:

Product Information

Dapagliflozin (ForxigaTM) is a new antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca, being approved by the European Medicines Agency (EMA) on November 12, 2012. It is also the first approved SGLT2 inhibitor for the treatment of type II diabetes, being an important option in the treatment of diabetes, and is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.

Product name	Dapagliflozin
CAS	461432-26-8
Appearance	white powder
Assay	99%
Storage	Cool and Protect from light

Usage

Dapagliflozin is a drug used to treat type 2 diabetes.It was developed by Bristol-Myers Squibb in partnership with
AstraZeneca.Although dapagliflozin's method of action would operate on both types of diabetes and other conditions
resulting in hyperglycemia, the current clinical trials specifically exclude participants with type 1 diabetes